CFAS Annual Meeting 2020 - Abstract Submission
At this present time, CFAS intends to host its Annual Meeting as planned during Sept. 10-12th, 2020, at the Westin Harbour Castle in downtown Toronto. However, we recognize that the research and clinic/lab operations of many of our members and prospective abstract submitters have been temporarily put on hold or otherwise slowed down as a result of the COVID-19 pandemic. Therefore, we have decided to extend the abstract submission deadline to May 30th, 2020. We hope this will provide submitters more time to conduct research or analyze data while still providing abstract reviewers with sufficient time to score abstracts. Please note that this extension also applies to grant applications and award nominations.
Please read the following information regarding abstract submission requirements, formatting, the review process, the notification of acceptance/rejection process, and other important information. The link to submit an abstract is at the bottom of the page.
You do not have to be a CFAS member to submit an abstract, but you must be a member in order to present your abstract if it is accepted.
Please read the guidelines below to ensure you meet all submission criteria and deadlines.
The Canadian Fertility and Andrology Society invites you to participate in the scientific program by submitting an abstract to be considered for presentation.
All abstracts and supporting files must be submitted through the electronic online Abstract Submitter (see below) as a PDF file. Do NOT submit MS Word Files or leave visible notes or track changes on your submitted abstracts.
Please complete all mandatory fields in the online submission form and attaching ALL of the following files (as PDFs):
- Your abstract, formatted as described below
- A blinded abstract (the same abstract, but with the author names and affiliations removed). This abstract will be provided to reviewers to ensure a fair, unbiased review.
- Ethical Standards Disclosure Forms for the author and ALL co-authors listed on the abstract
- NO abstracts submitted on paper will be accepted.
- NO faxed abstracts will be accepted
- NO emailed abstracts will be accepted (do not email abstracts to the CFAS Office)
- Abstracts that are not in PDF format will not be accepted
- NO ABSTRACTS REGARDING HUMAN REPRODUCTIVE CLONING WILL BE ACCEPTED
Abstracts submitted must contain original work and must not have been published previously or presented at a meeting of another national or international scientific organization prior to this meeting.
All individuals who require a visa to enter Canada are urged to begin making travel arrangements and obtaining necessary papers now to attend the meeting. A letter confirming registration to the meeting may be obtained by request at firstname.lastname@example.org. The letter does not imply any financial support by CFAS.
All abstracts must be submitted through the electronic online Abstract Submitter. Please be sure to review the submission criteria before submitting your abstract. If you require more information please contact the CFAS Office:
Canadian Fertility & Andrology Society
94 Avenue de la Presentation
Dorval, QC H9S 3L3
Submission Deadline and Guidelines
All abstracts must be submitted via the Online Submission system no later than May 30th, 2020.
Please note that the abstract deadline WILL NOT be extended.
Abstracts should be submitted in English only.
The success of any scientific meeting depends upon the quality of not only its plenary lectures, but also the free communications contributed by the registrants. Consequently, much thought has been devoted to ensuring that our meeting will provide the best possible forum for registrants to present their new and exciting research and clinical results.
As with every meeting there is a finite amount of time that can be dedicated in the program for presentation of oral free communications and many registrants’ work has to be assigned to poster presentations. Abstracts will be subject to anonymous peer review by 3 or more referees and, in general, those with the highest scores will be assigned oral presentation format.
Other accepted abstracts will be assigned to poster format presentation. If you are not willing to accept either an oral or a poster format presentation, you must indicate this at the time of submission.
Any topic relevant to human reproduction, assisted conception or reproductive genetics will be considered for inclusion in the meeting program. Abstracts must report results of a study or investigation. Any abstract not including adequate data, or saying that “results will be presented/discussed” will not be accepted. Appropriate statistical analysis of data must be presented.
Material submitted should not have been presented at a national or international meeting or published prior to our meeting.
By submitting an abstract, authors warrant that the work was conducted in complete accordance with any and all local, national and international ethical guidelines or regulations, including the Nuremberg Code and the Declaration of Helsinki.
- Use a structured layout for the abstract including headings (in bold): Introduction, Materials and Methods, Results, Discussion (or Conclusions), and References (if applicable).
- Authorship of abstracts should conform to international standards.
- The abstract should be typed single-spaced with one line of space between paragraphs and headings. Do not indent paragraphs.
- The body of the document should be no more than 375 words (2200 characters, including spaces, excluding references).
- Please make sure that the abstract file document is in a PDF format
- Introduction – should be informative and short, stating why the study was conducted
- Material & Methods – indicating the number and type of human subjects, non-human species or material being studied, the principal procedures, assays, tests or treatments performed
- Results – confirming or refuting the hypothesis, supported by statistics if appropriate
- Conclusions – stating the major new findings of the study and specifying what these findings add to what is known already
- References – proper citations, if applicable
Type the title in bold, authors in italics, and body in normal text.
Do not use all capital letters and do not indent.
Use a clear, legible 12 pt. black font (e.g. Calibri, Arial, Times New Roman)
The title should reflect the contents and should be no longer than 150 characters.
List all authors first name followed by family name followed by affiliation.
(i.e. 1 John Campbell, 2 Margaret Witherspoon;
1 University of Toronto, Ontario, Canada; 2 Fertility Clinic, Red Deer, Alberta, Canada)
SUBMIT AS A PDF FILE
The name of the first author is also the presenting author.
Do not include professional titles or degrees.
Graphic elements such as tables and graphs should be included in your document. However, please DO NOT incorporate any large graphic elements, as this will limit the amount of words you may include.
As a guide, all text and graphics must fit within a 7.5″ by 8″ box.
Abbreviations, acronyms and units:
Standard abbreviations and acronyms may be used without prior definition (e.g. IVF, OPU, GnRH, FSH, HSA, etc), but all non-standard terms must be defined where first used in the text.
SI units should be used throughout.
Identify significant differences using an italic capital letter “P”, e.g. P
Please check your abstract carefully; it will be published as submitted. DO NOT SUBMIT ABSTRACTS WITH TRACK CHANGES/MARK UP ON.
An Ethical Standards Disclosure Form for the presenter and EACH author must be completed for each submitted abstract.
All abstracts will be evaluated blindly by the Program Committee. You must submit both a regular abstract and a blinded abstract (names and affiliations removed).
You will be notified by email by once a list of accepted abstracts has been posted on the CFAS website. This list will also assign times, dates, and sessions, as well as identify the type of presentation (poster vs. oral communication) you have been assigned.
Only registered meeting participants will be accepted as abstract presenters. Submission of an abstract indicates acceptance of and compliance with the abstract submission guidelines. Guidelines for accepted poster and oral presentations are listed below.
Click the below link to submit an abstract. A grey "NEW SUBMISSION" button will appear. Click the button to begin your submission.
CLOSING DATE: May 30th, 2020
Guideline for Poster Presentations
- The poster board surface area is 2.44 metres wide by 1.22 metres high (4’ x 8′). Posters cannot exceed these dimensions. The standard poster size is 3' x 4'.
- Poster shall be affixed to the display boards with Pins or Velcro (male), which presenters are asked to bring; other sharp material is prohibited.
- In preparing your poster for the session, we suggest that you limit the amount of printed material to the least possible. Posters should not be elaborate, nor need they be expensive. If supplemental material is desired, you may hand out information sheets to those viewing your poster.
- Poster material must be prepared in advance and text should be large enough to be read from a distance of 1 metre (3.25′) or more.
- Each poster must have a top label indicating the title of the paper, the names of the authors and their affiliations. The size of the characters for the title should be at least one inch high.
- Keep illustrative material simple. Charts, drawings and illustrations are usually similar to those used in making slides preferably with bolder, heavier figures. Simple use of colour is effective for adding emphasis. Mount illustration on fairly stiff paper but NOT heavy cardboard.
- Simple “Introduction” and “Conclusion” sections are usually helpful. When feasible, use graphs for demonstrating qualitative relationships, use tables for precise numerical values. Photographs should be in a matte finish, not glossy.
- Do not fold posters; try to carry them in an appropriate container. Do not mail poster presentations in advance, they may not arrive in time; bring them with you to the Conference.
- Please note that there will be no audiovisual equipment in the non-moderated poster area.
- Meeting staff will be present to assist you.
Guideline for Oral Communications
Oral presentations will be 15 minutes long. Please allow 1-2 minutes for audience questions.